This story has been updated to provide comments from Biocept management made during a conference call with investors.

NEW YORK (GenomeWeb) - Biocept reported Wednesday after the close of the market that its fourth quarter revenues increased almost threefold year over year, primarily due to higher commercial test volume.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.